Patent Ruling Gives Lift to Pfizer ; Blood-Pressure Copycat Blocked

Summary


Pfizer Inc. won a major court ruling Friday that tightened its grip on its blockbuster blood-pressure drug and also could aid its pharmaceutical peers.

The U.S. Court of Appeals for the Federal Circuit in Washington reversed a lower court decision that would have helped pave the way for a copycat version of Pfizer's Norvasc to reach the market three years sooner than expected.

See the full content of this document

Extract


Patent Ruling Gives Lift to Pfizer ; Blood-Pressure Copycat Blocked

The ruling was a win for the branded pharmaceutical industry in i...

See the full content of this document

Sponsored links




ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

Contents in vLex United States

Explore vLex

For Professionals

For Partners

Company